The Market Reports

Synopsis
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Bone Morphogenetic Protein (BMP) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Human recombinant BMP7 has surgical uses and was originally marketed under the brand name OP1 (Olympus Biotech, who bought it from Stryker). It can be used to aid in the fusion of vertebral bodies to prevent neurologic trauma. rhBMP-7 has withdrawn off the market. rhBMP-4 and rhBMP-6 do not have commercial product launched. Therefore, in this report, we only study the rhBMP-2.
Bone Morphogenetic Protein 2 (BMP-2) is a member of the bone morphogenetic protein family, a group of proteins that play a crucial role in bone and cartilage formation during embryonic development and adult tissue repair. BMP-2 is known for its potent osteoinductive properties, meaning it has the ability to stimulate the differentiation of mesenchymal stem cells into osteoblasts, the cells responsible for bone formation. This property makes BMP-2 a valuable therapeutic agent in orthopedic and dental surgeries, particularly in procedures aimed at promoting bone regeneration and spinal fusion.
The global core manufacturers of Bone Morphogenetic Protein (BMP) include Medtronic, Jiuyuan Gene Engineering and Cellumed. The top three companies have a market share of about 99%. North America is the largest global market for Bone Morphogenetic Protein (BMP) with a market share of approximately 69%, followed by Asia Pacific and Europe with a market share of 19% and 9%, respectively. In terms of application, Spinal Fusion is the largest downstream segment, accounting for approximately 73% of the market.
This report aims to provide a comprehensive presentation of the global market for Bone Morphogenetic Protein (BMP), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bone Morphogenetic Protein (BMP) by region & country, by Type, and by Application.
The Bone Morphogenetic Protein (BMP) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Morphogenetic Protein (BMP).
Market Segmentation
By Company
Medtronic
Jiuyuan Gene Engineering
Cellumed
Segment by Type
Sponge Carrier
Hydroxyapatite Carrier
Segment by Application
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bone Morphogenetic Protein (BMP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bone Morphogenetic Protein (BMP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bone Morphogenetic Protein (BMP) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index